Andrew Arno
CIK: 0001472122
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jul 1, 2026IMDX
Insight Molecular Diagnostics Inc.
Tax Payment(F)Direct12.1K shares at avg. $5.69$69K - Jun 11, 2026IMDX
Insight Molecular Diagnostics Inc.
Award(A)Direct32.3K shares- - Mar 26, 2026VTAK
Catheter Precision, Inc.
Award(A)DirectOptions (Right to Buy)
40K shares- - Mar 9, 2026SMSI
SMITH MICRO SOFTWARE, INC.
Award(A)Direct12.5K shares- - Nov 10, 2025XXII
22nd Century Group, Inc.
Award(A)Direct17.3K shares- - Oct 9, 2025SMSI
SMITH MICRO SOFTWARE, INC.
Award(A)Direct8K shares- - Aug 12, 2025VTAK
Catheter Precision, Inc.
Award(A)DirectOptions (Right to Buy)
50K shares- - Jul 1, 2025IMDX
Insight Molecular Diagnostics Inc.
Award(A)Direct55K shares- - Mar 10, 2025XXII
22nd Century Group, Inc.
Award(A)Direct4.2K shares- - Jan 29, 2025VTAK
Catheter Precision, Inc.
Award(A)DirectStock Option
100K shares- - Jan 23, 2025SMSI
SMITH MICRO SOFTWARE, INC.
Award(A)Direct25K shares- - Dec 26, 2024OCX
Oncocyte Corp
Purchase(P)Direct12.5K shares at avg. $2.11$26K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 |  IMDX Insight Molecular Diagnostics Inc. | Tax Payment(F) | 12,100 | $5.69 | $68,849 | Direct |
| Jun 11, 2026 | IMDX Insight Molecular Diagnostics Inc. | Award(A) | 32,331 | - | $0 | Direct |
| Mar 26, 2026 |  VTAK Catheter Precision, Inc. | Award(A) Options (Right to Buy) | 40,000 | - | - | Direct |
| Mar 9, 2026 |  SMSI SMITH MICRO SOFTWARE, INC. | Award(A) | 12,500 | - | $0 | Direct |
| Nov 10, 2025 |  XXII 22nd Century Group, Inc. | Award(A) | 17,295 | - | - | Direct |
| Oct 9, 2025 | SMSI SMITH MICRO SOFTWARE, INC. | Award(A) | 7,993 | - | - | Direct |
| Aug 12, 2025 | VTAK Catheter Precision, Inc. | Award(A) Options (Right to Buy) | 50,000 | - | - | Direct |
| Jul 1, 2025 | IMDX Insight Molecular Diagnostics Inc. | Award(A) | 55,000 | - | - | Direct |
| Mar 10, 2025 | XXII 22nd Century Group, Inc. | Award(A) | 4,237 | - | - | Direct |
| Jan 29, 2025 | VTAK Catheter Precision, Inc. | Award(A) Stock Option | 100,000 | - | - | Direct |
| Jan 23, 2025 | SMSI SMITH MICRO SOFTWARE, INC. | Award(A) | 25,000 | - | $0 | Direct |
| Dec 26, 2024 |  OCX Oncocyte Corp | Purchase(P) | 12,500 | $2.11 | $26,350 | Direct |
1-12 of 12 transactions
About Arno Andrew
Arno Andrew (SEC CIK 0001472122) files insider reports with the SEC as Director of Insight Molecular Diagnostics Inc. (IMDX), Director of Catheter Precision, Inc. (VTAK) and Director of SMITH MICRO SOFTWARE, INC. (SMSI). Signal8 also holds filings tied to 1 other company.
Signal8 holds 13 ownership filings by Arno Andrew (1 Form 3, 12 Form 4), filed between Nov 8, 2024 and Jul 6, 2026. Those filings report 12 transactions, from Dec 26, 2024 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Arno Andrew's filings is in NASHVILLE, TN.
Recent filings by Arno Andrew
- Jul 1, 2026: Tax withholding of IMDX shares (Form 4, code F).
- Jun 11, 2026: Grant or award of IMDX shares (Form 4, code A).
- Mar 26, 2026: Grant or award of VTAK derivative securities (Form 4, code A).
- Mar 9, 2026: Grant or award of SMSI shares (Form 4, code A).
- Nov 10, 2025: Grant or award of XXII shares (Form 4, code A).
Other insiders filing for Insight Molecular Diagnostics Inc. (IMDX)
- SILVERMAN LOU, Director
- Last Andrew J., Director
- BROADWOOD PARTNERS, L.P., 10% Owner
- James Andrea S., Chief Financial Officer
- Liu James Yang, VP ACCT, Cntlr, Treasurer, PAO
- Riggs Josh, CEO and President